These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 787564)

  • 1. Intrathecal amikacin administration. Use in the treatment of gentamicin-resistant Klebsiella pneumoniae meningitis.
    Hamory B; Ignatiadis P; Sande MA
    JAMA; 1976 Oct; 236(17):1973-4. PubMed ID: 787564
    [No Abstract]   [Full Text] [Related]  

  • 2. Klebsiella meningitis treated with intrathecal amikacin.
    Block CS; Cassel R; Koornhof HJ; Robinson RG; Lewer-Allen CM
    Lancet; 1977 Jun; 1(8026):1371-2. PubMed ID: 69095
    [No Abstract]   [Full Text] [Related]  

  • 3. Emergence of multiple antibiotic resistance during the therapy of Klebsiella pneumoniae meningitis.
    Barriere SL; Conte JE
    Am J Med Sci; 1980; 279(1):61-5. PubMed ID: 6989241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intraventricular amikacin in the treatment of meningoventriculitis caused by Gram-negative organisms].
    Ludeña Carpio C; Madero López L; Barrio Corrales F; Lozano Jiménez C; Martínez Beltrán J; Loza E
    An Esp Pediatr; 1981 Nov; 15(5):503-6. PubMed ID: 7036809
    [No Abstract]   [Full Text] [Related]  

  • 5. Experience with amikacin and colistin in an outbreak of infection by resistant Klebsiella aerogenes.
    Speller DC; Bint AJ; Stephens M
    J Antimicrob Chemother; 1977 Sep; 3(5):483-91. PubMed ID: 332682
    [No Abstract]   [Full Text] [Related]  

  • 6. Intraventricular administration of amikacin for complicated Gram-negative meningitis and ventriculitis.
    Wirt TC; McGee ZA; Oldfield EH; Meacham WF
    J Neurosurg; 1979 Jan; 50(1):95-9. PubMed ID: 363982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intrathecal administration of amikacin in postoperative refractory meningitis].
    Yamashima T; Shoin K; Someya S; Kogure Y; Kubota T; Yamamoto S
    Jpn J Antibiot; 1983 Mar; 36(3):522-8. PubMed ID: 6688276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum beta-lactamase.
    Smith CE; Tillman BS; Howell AW; Longfield RN; Jorgensen JH
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1290-3. PubMed ID: 2203306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amikacin therapy of gram-negative bacteremia and meningitis. Treatment in diseases due to multiple resistant bacilli.
    Sklaver AR; Greenman RL; Hoffman TA
    Arch Intern Med; 1978 May; 138(5):713-6. PubMed ID: 348135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental infection in rabbits evoked by Pseudomonas aeruginosa, Proteus mirabilis, Escherichia coli and Klebsiella pneumoniae treated with gentamicin, amikacin and sisomicin.
    Jeljaszewicz J; Włodarczak K; Bis W; Kazanowski A; Kuzniewski P; Molska J
    Zentralbl Bakteriol A; 1980 Aug; 247(3):347-52. PubMed ID: 6999802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bactericidal activity of amikacin and gentamicin.
    Shah RM; Heetderks G; Stille W
    Chemotherapy; 1977; 23(4):260-6. PubMed ID: 405182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of intrathecal amikacin in the treatment of postoperative meningitis (author's transl)].
    Takagi K; Fukushima T
    Jpn J Antibiot; 1980 Jun; 33(6):664-7. PubMed ID: 6893845
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple antibiotic resistance and capsular types of gentamicin-resistant Klebsiella aerogenes.
    Casewell MW; Talsania HG
    J Antimicrob Chemother; 1981 Mar; 7(3):237-44. PubMed ID: 7024241
    [No Abstract]   [Full Text] [Related]  

  • 14. [A case of Klebsiella pneumonia with complication of CO2-narcosis successfully treated with amikacin (author's transl)].
    Nakagami K; Yatani Y; Osakabe Y; Kunieda T; Suzuki H; Satomi T; Saruta E; Noguchi E
    Jpn J Antibiot; 1980 May; 33(5):641-4. PubMed ID: 7001088
    [No Abstract]   [Full Text] [Related]  

  • 15. Loss of an aminoglycoside resistance plasmid by Serratia marcescens during treatment of meningitis with amikacin.
    Rubens CE; McGee ZA; Farrar WE
    J Infect Dis; 1980 Mar; 141(3):346-50. PubMed ID: 6988523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Klebsiella neonatal injections: mechanism of broadening aminoglycoside resistance.
    Hardy DJ; Legeai RJ; O'Callaghan RJ
    Antimicrob Agents Chemother; 1980 Oct; 18(4):542-8. PubMed ID: 7004341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of ventriculitis caused by
    Gofman N; To K; Whitman M; Garcia-Morales E
    Am J Health Syst Pharm; 2018 Jul; 75(13):953-957. PubMed ID: 29941534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. R-factor mediated gentamicin resistance in "Klebsiella aerogenes". A new problem in nosocomial infection.
    Casewell MW
    Quad Sclavo Diagn; 1979 Jun; 15 Suppl 1():419-33. PubMed ID: 400250
    [No Abstract]   [Full Text] [Related]  

  • 19. Relapse of gram-negative bacillary meningitis after cefotaxime therapy.
    Bradsher RW
    JAMA; 1982 Sep; 248(10):1214-5. PubMed ID: 6287048
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined intrathecal and intramuscular gentamicin for gram-negative meningitis. Pharmacologic study of 21 patients.
    Rahal JJ; Hyams PJ; Simberkoff MS; Rubinstein E
    N Engl J Med; 1974 Jun; 290(25):1394-8. PubMed ID: 4208369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.